During slow wave sleep (SWS) pituitary responsiveness to CRH is reduced. Since GHRH is involved in the promotion of SWS in humans and rats, it was examined whether the blunted CRH-induced ACTH and cortisol release during SWS could be mimicked by systemic GHRH. Young healthy men (n = 7) participated in 4 sleep-endocrine protocols: (A) lights off at 23.00 h, intravenous injection of 50 µg CRH during the first SWS period; (B) lights off at 01.00 h, injection of 100 µg GHRH at 23.00 h, followed by 50 µg CRH at 23.30 h; (C) lights off at 01.00 h, injection of 50 µg CRH at 23.30 h, and (D) lights off at 23.00 h, saline treatment only (= baseline condition). The sleep EEG was recorded during the lights off period and blood samples, collected every 20 min between 22.00 and 07.00 h, were assayed for GH, cortisol and ACTH. There was no significant difference in the sleep-associated GH peak between protocols. Plasma ACTH was significantly higher following CRH administration during wakefulness compared with CRH administration during SWS (protocols B and C vs. A; area under the curve (AUC) 23.00–03.00 h: 9.6 ± 4.8 and 7.3 ± 2.0 vs. 6.1 ± 1.1 ng/ml × min; p < 0.05), while there was no significant difference in plasma ACTH concentration between the baseline condition and protocol A (CRH administration during SWS). Similarly, cortisol was significantly enhanced compared with baseline following CRH during wakefulness only. CRH induced an increase in EEG activity in the sigma frequency range, both when it was administered during wakefulness and SWS, while this effect was reduced by pre-treatment with GHRH. In summary, our data suggest that (1) the blunted CRH-induced release of ACTH and cortisol during SWS is not mimicked by systemic GHRH administration, and (2) CRH enhances sigma EEG activity possibly via modulation of afferent pathways from the median eminence to the thalamus and this effect is reduced by pre-treatment with GHRH.

Keywords:
Growth hormone, Adrenal steroids, Growth hormone-releasing hormone, Corticotropin, Clinical neuroendocrinology, Sleep
1.
al-Damluji S: Adrenergic control of the secretion of anterior pituitary hormones. Baillières Clin Endocrinol Metab 1993;7:355–392.
2.
Andersson K, Agnati LF, Fuxe K, Eneroth P, Harfstrand A, Benfenati F: Corticotropin-releasing factor increases noradrenaline turnover in the median eminence and reduces noradrenaline turnover in the paraventricular region of the hypophysectomized male rat. Acta Physiol Scand 1984;120:621–624.
3.
Aston-Jones G, Bloom FE: Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876–886.
4.
Bierwolf C, Struve K, Marshall L, Born J, Fehm HL: Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. J Neuroendocrinol 1997;9:479–484.
5.
Bohlhalter S, Murck H, Holsboer F, Steiger A: Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects. Neurobiol Aging 1997;18:423–429.
6.
Born J, Steinbach D, Dodt C, Fehm HL: Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab 1997;82:1106–1110.
7.
Chronwall BM: Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 1985;6(suppl 2):1–11.
8.
Dijk DJ, Czeisler CA: Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995;15:3526–3538.
9.
Eberly LB, Dudley CA, Moss RL: Iontophoretic mapping of corticotropin-releasing factor (CRF) sensitive neurons in the rat forebrain. Peptides 1983;4:837–841.
10.
Ehlers CL, Kupfer DJ: Hypothalamic peptide modulation of EEG sleep in depression: a further application of the S-process hypothesis. Biol Psychiatry 1987;22:513–517.
11.
Ehlers CL, Reed TK, Henriksen SJ: Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986;42:467–474.
12.
Friess E, von Bardeleben U, Wiedemann K, Lauer C, Holsboer F: Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. J Sleep Res 1994;3:73–79.
13.
Friess E, Wiedemann K, Steiger A, Holsboer F: The hypothalamic-pituitary-adrenocortical system and sleep in man. Adv Neuroimmunol 1995;5:111–125.
14.
Guldner J, Schier T, Friess E, Colla M, Holsboer F, Steiger A: Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging 1997;18:491–495.
15.
Holsboer F, von Bardeleben U, Steiger A: Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 1988;48:32–38.
16.
Iovino M, Monteleone P, Steardo L: Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) respone to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989;69:910–913.
17.
Juhasz G, Emri Z, Kekesi KA, Salfay O, Crunelli V: Blockade of thalamic GABAB receptors decreases EEG synchronization. Neurosci Lett 1994;172:155–158.
18.
Juhasz G, Kekesi KA, Emri Z, Ujszaszi J, Krogsgaard-Larsen P, Schousboe A: Sleep promoting effect of a putative glial gamma-aminobutyric acid uptake blocker applied in the thalamus of cats. Eur J Pharmacol 1991;209:131–133.
19.
Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G: Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 1993;264:E594–E598.
20.
Larsen PJ, Moller M, Mikkelsen JD: Efferent projections from the periventricular and medial parvicellular subnuclei of the hypothalamic paraventricular nucleus to circumventricular organs of the rat: a Phaseolus vulgaris-leucoagglutinin (PHA-L) tracing study. J Comp Neurol 1991;306:462–479.
21.
Lauer C, Riemann D, Wiegand M, Berger M: From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 1991;29:979–993.
22.
Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van Cauter E: 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987;65:141–152.
23.
Marshall L, Boes N, Strasburger C, Born J, Fehm HL: Differential influences on sleep of growth-hormone releasing hormone at different concentrations. Exp Clin Endocrinol Diabetes 1997;105(suppl 1):113.
24.
Marshall L, Mölle M, Böschen G, Steiger A, Fehm HL, Born J: Greater efficacy of episodic than continuous growth hormone releasing hormone (GHRH) administration in promoting slow wave sleep (SWS). J Clin Endocrinol Metab 1996;81:1009–1013.
25.
Meister B, Hökfelt T: Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 1988;2:585–605.
26.
Nunez A, Curró Dossi R, Contreras D, Steriade M: Intracellular evidence for incompatibility between spindle and delta oscillations in thalamocortical neurons of cat. Neuroscience 1992;48:75–85.
27.
Obál F Jr, Alföldi P, Cady AB, Johannsen L, Sary G, Krueger JM: Growth hormone-releasing factor enhances sleep in rats and rabbits. Am J Physiol 1988;255:R310–R316.
28.
Obál F Jr, Floyd R, Kapás L, Bodos B, Krueger JM: Effects of systemic GHRH on sleep in intact and in hypophysectomized rats. Am J Physiol 1996;270:E230–E237.
29.
Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, US Deparment of Health, Education & Welfare, Neurological Information Network, 1968.
30.
Späth-Schwalbe E, Uthgenannt D, Voget G, Kern W, Born J, Fehm HL: Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab 1993;77:1170–1173.
31.
Steiger A, Guldner J, Colla-Müller M, Friess E, Sonntag A, Schier T: Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression. J Psychiatr Res 1994;28:225–238.
32.
Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F: Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992;56:566–573.
33.
Steiger A, Holsboer F: Neuropeptides and human sleep. Sleep 1997;20:1038–1052.
34.
Steiger A, von Bardeleben U, Herth T, Holsboer F: Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 1989;16:189–195.
35.
Szafarczyk A, Alonso G, Ixart G, Malaval F, Assenmacher I: Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol 1985;249:E219–E226.
36.
Takahashi T, Okimura Y, Yoshimura K, Shigeyoshi Y, Kaji H, Abe H, Chihara K: Regional distribution of growth hormone-releasing hormone (GHRH) receptor mRNA in the rat brain. Endocrinology 1995;136:4721–4724.
37.
Weindl A: Neuroendocrine aspects of circumventricular organs; in Ganong WF, Martini L (eds): Frontiers in Neuroendocrinology, 1973. New York, Oxford University Press, 1973, pp 3–32.
38.
Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J: Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 1983;56:352–358.
39.
Wong ML, Licinio J, Pasternak KI, Gold PW: Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 1994;135:2275–2278.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.